Literature DB >> 35192044

Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT.

Yong Jae Kwon1, Kyoung Doo Song2, Seong Eun Ko1, Jeong Ah Hwang1, Minji Kim3.   

Abstract

PURPOSE: To evaluate the diagnostic performance and inter-observer variability of differentiating T1 and T2 gallbladder (GB) cancers using multi-detector row CT (MDCT).
METHODS: This retrospective study included 151 patients with surgically confirmed T1 (n = 49)- or T2 (n = 102)-stage GB cancer who underwent contrast-enhanced MDCT from 2016 to 2020. Five radiologists (two experienced and three less experienced) evaluated the T-stage with a confidence level calculated using a six-point scale. GB cancers were morphologically classified into three types: polypoid, polypoid with wall thickening, and wall thickening. The diagnostic performance of T-staging was assessed using receiver operating characteristic (ROC) curve analysis. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated based on a binary scale (T1 = positive). Inter-observer agreement was assessed using Fleiss κ statistics.
RESULTS: The area under the receiver operating characteristic (ROC) curve of each reviewer for T-staging ranged from 0.69 to 0.80 (median 0.77). The overall accuracy of the five radiologists was 78% (95% confidence interval [CI] 71-84%). Sensitivity was higher and specificity was lower in experienced radiologists than in less experienced radiologists (P < 0.001). The overall inter-observer agreement was fair (κ = 0.36; 95% CI 0.31, 0.41). The overall accuracy for T-stage was 63% (95% CI 48-76), 78% (95% CI 63-88), and 87% (95% CI 77-93) for polypoid, polypoid with wall thickening, and wall thickening type, respectively.
CONCLUSION: The accuracy of MDCT for differentiating T1 and T2 GB cancer is limited, and there is considerable inter-observer variability.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Computed tomography; Diagnostic performance; Early stage; Gallbladder cancer; Inter-observer variability

Mesh:

Year:  2022        PMID: 35192044     DOI: 10.1007/s00261-022-03450-3

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  13 in total

1.  Early gallbladder carcinoma does not warrant radical resection.

Authors:  T Wakai; Y Shirai; N Yokoyama; S Nagakura; H Watanabe; K Hatakeyama
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

Review 2.  Gallbladder cancer worldwide: geographical distribution and risk factors.

Authors:  Giorgia Randi; Silvia Franceschi; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

3.  Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study.

Authors:  Hyeong Seok Kim; Jae Woo Park; Hongbeom Kim; Youngmin Han; Wooil Kwon; Sun-Whe Kim; Yoon Jin Hwang; Sang Geol Kim; Hyung Jun Kwon; Eduardo Vinuela; Nicolas Járufe; Juan Carlos Roa; In Woong Han; Jin Seok Heo; Seong-Ho Choi; Dong Wook Choi; Keun Soo Ahn; Koo Jeong Kang; Woohyung Lee; Chi-Young Jeong; Soon-Chan Hong; Andres Troncoso; Hector Losada; Sung-Sik Han; Sang-Jae Park; Hiroaki Yanagimoto; Itaru Endo; Keiichi Kubota; Toshifumi Wakai; Tetsuo Ajiki; Nazmi Volkan Adsay; Jin-Young Jang
Journal:  J Hepatobiliary Pancreat Sci       Date:  2018-12       Impact factor: 7.027

4.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J W Valle; I Borbath; S A Khan; F Huguet; T Gruenberger; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

5.  Worldwide Burden of and Trends in Mortality From Gallbladder and Other Biliary Tract Cancers.

Authors:  Lindsey A Torre; Rebecca L Siegel; Farhad Islami; Freddie Bray; Ahmedin Jemal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-08-18       Impact factor: 11.382

Review 6.  Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis.

Authors:  Hongeun Lee; Wooil Kwon; Youngmin Han; Jae Ri Kim; Sun-Whe Kim; Jin-Young Jang
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-14       Impact factor: 7.027

7.  Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients.

Authors:  Kiyoaki Ouchi; Junichi Mikuni; Yoichiro Kakugawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

8.  Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea.

Authors:  Seung Eun Lee; Jin-Young Jang; Sun-Whe Kim; Ho-Seong Han; Hong-Jin Kim; Sung-Su Yun; Baik-Hwan Cho; Hee Chul Yu; Woo Jung Lee; Dong-Sup Yoon; Dong Wook Choi; Seong-Ho Choi; Soon-Chan Hong; Sang-Mok Lee; Hyun Jong Kim; In Seok Choi; In-Sang Song; Sang-Jae Park; Sungho Jo
Journal:  Ann Surg Oncol       Date:  2014-04-18       Impact factor: 5.344

9.  MDCT in the staging of gallbladder carcinoma.

Authors:  Naveen Kalra; Sudha Suri; Rajesh Gupta; S K Natarajan; Niranjan Khandelwal; J D Wig; Kusum Joshi
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

10.  Practical guidelines for the surgical treatment of gallbladder cancer.

Authors:  Seung Eun Lee; Kyung Sik Kim; Wan Bae Kim; In-Gyu Kim; Yang Won Nah; Dong Hee Ryu; Joon Seong Park; Myung Hee Yoon; Jai Young Cho; Tae Ho Hong; Dae Wook Hwang; Dong Wook Choi
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.